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Background: Ticks are distributed worldwide and considered as vectors of many human diseases. Tick defensins,
a family of antimicrobial peptides, form the first line of defense against pathogens.
Findings: A defensin-like gene, named Ds-defensin, was identified from a cDNA library of the hard tick Dermacentor
silvarum collected from northeast China. The full-length cDNA of Ds-defensin was 225 bp, encoding a 74 amino acid
peptide. The nucleotide sequence of Ds-defensin shared 98.2% similarity to putative defensin from Dermacentor
marginatus. RT-PCR results suggested that Ds-defensin was extensively expressed in tick salivary gland and
midgut, with a higher expression level in midgut. Ds-defensin showed broad antimicrobial activity against various
Gram-positive and Gram-negative bacteria, as well as the fungus Candida albicans.
Conclusions: We characterized a functional defensin from D. silvarum of China. Ds-defensin showed bactericidal
activity against various Gram-positive and Gram-negative bacteria. Ds-defensin can be expected to be introduced to
the medical field as a new molecule with antibacterial activity.
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Ticks, important medical arthropods, have great effects on
animal and human health by transmitting various patho-
gens worldwide. Tick-borne pathogens include viruses,
spirochetes, rickettsia, bacteria, and protozoa. They cause
diseases such as tick-borne encephalitis, Crimean-Congo
hemorrhagic fever, Lyme disease, Q fever, and Rocky
Mountain spotted fever. In recent years, a new series of
tick-borne diseases have posed a threat to the survival of
mankind [1,2]. Many serological surveys also indicated the
existence of populations with a variety of tick-borne infec-
tious disease antibodies [3,4].
Hard ticks feed on mammals for a long time (several
days), so that they have many opportunities to encounter
microbes. Ticks do not have lymphocytes, thymuses, or
antibodies. They rely heavily on antimicrobial peptides
(AMPs) to defend against microbes so that they can live
harmoniously with microbes [5,6]. AMPs are innate im-
mune molecules that kill pathogenic microbes. Defensin* Correspondence: ttfeng@suda.edu.cn; daijianfeng@suda.edu.cn
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lated from many species, including mammals, insects,
and plants, and provide initial defense against infectious
pathogens [7,8]. Several defensins and their isoforms
have been identified in tick species including Ixodes sca-
pularis, Amblyomma americanum, Dermacentor varia-
bilis, Rhipicephalus microplus, Ornithodoros moubata,
Ixodes ricinus, Amblyomma hebraeum and Haemaphy-
salis longicornis ticks [9-13]. Tick defensins usually con-
tain six cysteine residues, and are usually expressed in
the midgut (MG) after blood feeding or pathogen inva-
sion [14,15]. Antimicrobial activity is primarily directed
against Gram-positive bacteria, but some isoforms are
also effective against Gram-negative bacteria, protozoa,
and yeasts [9,15-17].
In our study, we characterized a defensin gene from a
cDNA library of Dermacentor silvarum. This hard tick
species was collected in the field of Heilongjiang Prov-
ince, located in northeast China. It has been reported to
transmit human pathogens, such as tick-borne encephal-
itis virus, Anaplasma, and Rickettsia [18-20].
By sequencing a cDNA library of D. silvarum, a cDNA
clone encoding the precursor of a putative defensin was
obtained and named Ds-defensin. The cDNA sequenceThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wang et al. Parasites & Vectors  (2015) 8:25 Page 2 of 5and deduced amino acid sequence of Ds-defensin are
shown in Figure 1. Sequence analysis indicated that the
Ds-defensin cDNA was 225 bp long, encoding a 74
amino acid peptide. The predicted protein contained a
putative signal peptide cleavage site at amino acid posi-
tions 22 to 23, as analyzed by SignalP4.1 software
(http://www.cbs.dtu.dk/services/SignalP/). The sequence
of Ds-defensin cDNA has been deposited in GenBank
with accession number KJ885301.
To identify the evolutionary relationships between Ds-
defensin and other defensin-like genes in invertebrate
species, sequence alignment and phylogenetic analysis
were conducted using multiple sequence alignment soft-
ware Clustal X2 (http://www.clustal.org/). The nucleotide
sequence of Ds-defensin shared 98.2% identity with a
putative defensin from Dermacentor marginatus, and their
amino acid sequences were 100% identical, suggesting that
these two tick species were closely related (Figure 2).
Sequence alignment results suggest that Ds-defensin
shared high similarity to putative defensins from hard tick
species, such as R. microplus (79.73%), I. ovatus (58.11%),
I. persulcatus (59.46%), and A. americanum (55.56%), and
low similarity to putative defensins from soft ticks, such as
O. moubata (43.84%), O. papillipes (43.84%), O. rostratus
(43.84%), and C. puertoricensis (43.84%). All these defen-
sins contained six conserved cysteine residues, including
defensins from fruit fly (Drosophila melanogaster) or mar-
ine mollusk species (Crassostrea gigas and Ruditapes
philippinarum) (Figure 2A). Phylogenetic tree analysis
also suggested that these putative defensin sequences
fell into three distinct clusters. One cluster comprised
defensins from hard ticks (D. silvarum, D. marginatus,
R. microplus, A. monolakensis, A. americanum, I. ovatus,
and I. persulcatus). Another cluster comprised defensins
from soft ticks (O. moubata, O. papillipes, O. rostratus,
and C. puertoricensis), and the other cluster comprised
defensins from marine mollusk species (A. americanum
and R. philippinarum) (Figure 2B). Although defensins
were evolutionarily conserved at the critical amino acid
positions (six cysteine residues), they also exhibited signifi-
cant changes during evolution.Figure 1 Nucleotide and deduced amino acid sequences of
Ds-defensin from Dermacentor silvarum. Putative signal peptide
of Ds-defensin, as predicted by SignalP 4.1 server, is underlined.To investigate the mRNA expression of Ds-defensin in
different tissues of D. silvarum, RNA was extracted from
whole ticks, salivary gland (SG), and midgut (MG).
Transcript expression analysis of the Ds-defensin gene
was conducted by RT-PCR using Ds-defensin gene-
specific primers. As shown in Figure 3, Ds-defensin was
extensively expressed in MG and SG, and the expression
level in MG was significantly higher than that in SG or
whole ticks (Figure 3B). These data were consistent with
previous findings, and suggest that Ds-defensin may play
important roles in protecting ticks against microorgan-
isms in MG and SG.
To test the antimicrobial activity of Ds-defensin, the
mature form of Ds-defensin (a 52 amino acid peptide)
was synthesized and purified by high-performance liquid
chromatography (GL Biochem, Shanghai, China). The
peptide was dissolved in PBS buffer containing 0.05%
Tween 20 and 1 μM β-merkaptoethanol (at a stock con-
centration of 1000 μM), and diluted properly when used
in the antimicrobial assay. The target bacteria used
in the bactericidal assay were purchased from China
Veterinary Culture Collection Center (CVCC). Four
Gram-positive bacteria, namely, Staphylococcus aureus
(CMCC26003), Bacillus pumilus (CMCC63202), Micro-
coccus luteus (CMCC63202), and Mycobacterium bovis
(carbenicillin-resistant strain); and three Gram-negative
bacteria, namely, Salmonella typhimurium (CVCC542),
Pseudomonas aeruginosa (CVCC2000), and Escherichia
coli (CMCC44103), were used in this study. Microbial
strains were grown to an OD600nm of 0.4–0.6 at 37°C in
Poor Broth media (1% w/v tryptone and 1% w/v NaCl)
(except for M. bovis, which was grown in Middlebrook
7H9 Broth (BD-Difco, USA) with carbenicillin). Ap-
proximately 90 μL of inocula of microbial strains (di-
luted with PB media to an OD600nm of 0.01) and 10 μL
of various concentrations of Ds-defensin (0.1–50 μM)
were added to the well of a 96-well plate. The mixture
was grown for 20 h (for M. bovi, incubated for 48 h) at
37°C and 250 rpm. Antimicrobial activity was evaluated
by measuring the absorbance of the bacterial culture at
OD600nm. As shown in Table 1, Ds-defensin showed sig-
nificant antimicrobial activities against Gram-positive
bacteria with a minimal inhibitory concentration (MIC)
less than 50 μM. For B. pumilus, Ds-defensin showed
potent antimicrobial activities at 1 μM. Ds-defensin was
less effective to Gram-negative bacteria. The MIC values
to S. typhimurium and P. aeruginosa were greater than
50 μM. Ds-defensin did not inhibit the growth of E. coli,
but it significantly inhibited the growth of antibiotic-
resistant M. bovis (MIC = 20 μM). To test whether
Ds-defensin also influences the growth of fungi, Candida
albicans (CAU0037) was used in the antimicrobial assay.
C. albicans replication was significantly inhibited when
the concentration of Ds-defensin exceeded 10 μM in
Table 1 Antimicrobial activity of Ds-defensin
Figure 2 Sequence alignment (A) and phylogenetic tree (B) constructed with sequences of putative defensins from Dermacentor
silvarum and other species. Ds-defensin is indicated with a red asterisk. Sequence GenBank accession numbers: Rhipicephalus microplus
[AAO48943], Ornithodoros moubata [BAB41028], Ornithodoros papillipes [ACJ04425.1], Ornithodoros rostratus [ACJ04428.1], Carios puertoricensis
[ACJ04429.1], Argas monolakensis [ABI52766.1], Dermacentor marginatus [ACJ04433.1], Ixodes ovatus [BAH09305.1], Ixodes persulcatus [BAH09304.1],
Amblyomma americanum [ABI74752.1], Ruditapes philippinarum [ADO32580.1], Crassostrea gigas [ACQ76287.1], and Drosophila melanogaster
[AAF58855.1].
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the MIC to C. albicans was greater than 50 μM (Table 1).
As shown by hemolytic assay, Ds-defensin was harmless
to human erythrocytes, in concentrations of up to
20 μM (Additional file 1: Figure S1, A). Furthermore,
Ds-defensin showed no detectable cytotoxicity to mam-
malian cell lines (Additional file 1: Figure S1, B), and did
not infect the replication of vesicular stomatitis virus
(VSV) in 293 T cells (data not shown).
Defensins are present in all types of organisms from
humans and plants to arthropods. Defensins are AMPs
that form the first line of defense against pathogens. A
common function of defensins from all organisms is to
lyse bacterial cells; however, the amino acid sequences ofFigure 3 Expression of Ds-defensin mRNA in ticks. (A)
Expression of Ds-defensin in tick salivary gland (SG) and midgut
(MG) as determined by RT-PCR. Tick actin gene was amplified as the
loading control. (B) Relative expression level of Ds-defensin in SG,
MG, and whole ticks, as determined by quantitative RT-PCR. The
copy number of Ds-defensin was normalized to tick actin. Results
are expressed as the mean + SEM. Results represent at least three
independent experiments.defensins show high diversity. Sequence analysis showed
that the Ds-defensin peptide had 98.2% identity at the
nucleotide level and 100% identity at the amino acid
level to a putative defensin from D. marginatus, another
hard tick species. Our data also show that defensins
from hard and soft ticks shared a high degree of variabil-
ity. The differentiation could be influenced by a diverse
strategy of blood intake and types of pathogens that each
tick species has encountered during their evolutionary
history and geographical isolation [21].
The incidence of tick-borne diseases has steadily in-
creased over the past few years, and effective vaccinesStrain of microbes MIC (μM)
Gram-positive bacteria
Bacillus pumilus (CMCC63202) 1
Staphylococcus aureus (CMCC26003) 20
Micrococcus luteus (CMCC63202) 50
Mycobacterium bovis (carbenicillin-resistant) 20
Gram-negative bacteria
Salmonella typhimurium (CVCC542) >50
Pseudomonas aeruginosa (CVCC2000) >50
Escherichia coli (CMCC44103) no effect
Fungus
Candida albicans (CAU0037) >50
MIC: minimal peptide concentration required for total inhibition of cell growth
in liquid medium. Determination of MICs was performed at least three times
in triplicates.
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able [22]. Defensin is an AMP that is not yet affected by
antibiotic-resistance mechanisms [23]. Defensins have
been identified in both soft and hard ticks, and they
show different profiles of antimicrobial activity. For ex-
ample, Chrudimská and colleagues characterized two
defensin isoforms (Def1 and Def2) from the hard tick
I. ricinus, and showed that both Def1 and Def2 have
significant bactericidal effects on Gram-positive bacteria
but they are insensitive to Gram-negative bacteria,
yeasts, and viruses [24]. The same group recently charac-
terized another defensin (defDM) from the hard tick
D. marginatus, and suggested that defDM has inhibitory
effects on Gram-positive bacteria and a popular tick-borne
pathogen Borrelia afzelii [25]. Lu et al. reported that a
defensin-like peptide (DLP) from hard tick H. longicornis
has potent antimicrobial activities against bacteria and
fungi (C. albicans), and even shows strong antimicrobial
ability against drug-resistant microorganisms [6]. A recent
review by Wang et al. summarized that the hard tick
I. scapularis has two multigene families of DLPs [26]. The
core region of I. scapularis defensin scapularisin-20 ex-
hibits a wide spectrum of antimicrobial activity against
both Gram-positive and Gram-negative bacteria, with
higher potency to Gram-positive bacteria than to Gram-
negative bacteria. The novel defensin we identified from
the hard tick D. silvarum also has a distinct antimicrobial
profile to different microbes. Ds-defensin showed strong
potency against some Gram-positive bacteria (S. aureus,
B. pumilus, M. luteus, and M. bovis), but had less effect on
Gram-negative bacteria (S. typhimurium, P. aeruginosa,
and E. coli). At a dose higher than 10 μM, Ds-defensin
showed significant antifungal activity against C. albicans
growth and could inhibit the antibiotic-resistant strain of
M. bovis. Ds-defensin was not hemolytic at 20 μM, and
had no detectable cytotoxicity against various human cells.
These data suggest that Ds-defensin could be safely used
in mammalian systems as a potential antimicrobial reagent
against various Gram-positive bacteria and some fungi.Additional file
Additional file 1: Figure S1. Hemolytic and cytotoxic assay of Ds-defensin.
(A) Hemolytic effect of Ds-defensin to mouse erythrocytes. Hemolytic activity
was measured by co-incubating 2% (vol/vol) erythrocyte suspension with
various concentration of Ds-defensin for 2 hours at 37°C. (B) Ds-defensin had
no cytotoxic effect on mammalian cell lines. Ds-defensin was added into
the cell media at a final concentration of 10 μM and incubated with various
cells for 24 h. The cell viabilities were measured using a CellTiter-Glo kit
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